THERAPY OBJECTIVES IN PATIENTS WITH METAS TASIZED BREAST-CANCER

Citation
K. Possinger et al., THERAPY OBJECTIVES IN PATIENTS WITH METAS TASIZED BREAST-CANCER, Schweizerische medizinische Wochenschrift, 125(27-28), 1995, pp. 1347-1353
Citations number
15
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00367672
Volume
125
Issue
27-28
Year of publication
1995
Pages
1347 - 1353
Database
ISI
SICI code
0036-7672(1995)125:27-28<1347:TOIPWM>2.0.ZU;2-9
Abstract
In patients with metastasized breast cancer cure is beyond our therape utic reach at present. In this situation the main treatment objectives are to improve existing or imminently threatening symptoms caused by the tumor growth, to retain or restore physical ability for as long as possible and, if possible, to prolong survival time. To achieve these treatment aims diphosphonates, hormones and cytotoxic mono- or polych emotherapies can be administered. The individualized administration of these drugs, adapted to the rate of the sprea of metastases and tumor -induced symptoms, help to attain long survival without pronounced tox ic side effects.